Robert Gundel

Robert Gundel

No más puestos en curso
Health Technology
Consumer Services
Finance

Perfil

Robert Gundel is the founder of Chatham Consulting Group, Inc. (founded in 2007).
He was the President, CEO & Non-Independent Director of ProMIS Neurosciences, Inc. from 2010 to 2015.
He held the position of Director-Pharmacology at Bayer Corp.
and Vice President-Pharmacology & Preclinical Research at Chiron Corp.
He was also the Chief Scientific Officer at Arius Research, Inc. in 2008 and Vice President-Research & Development at Elusys Therapeutics, Inc. in 2008.
In addition, he served as the Interim Chief Scientific & Technology Officer at Scorpius Holdings, Inc. in 2009 and Vice President-Scientific & Corporate Development at XOMA (US) LLC from 2005 to 2007.
Dr. Gundel holds an MBA from St. Mary's College of California and a doctorate from New York Medical College.

Antiguos cargos conocidos de Robert Gundel.

EmpresasCargoFin
PROMIS NEUROSCIENCES, INC. Director Ejecutivo 29/06/2015
SCORPIUS HOLDINGS, INC. Director Técnico/Científico/I+D 01/01/2009
Director Técnico/Científico/I+D 01/11/2008
Director Técnico/Científico/I+D 01/01/2008
Corporate Officer/Principal 01/01/2007
Ver el detalle de la experiencia de Robert Gundel.

Formación de Robert Gundel.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

24

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Finance